Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goel, A.
Right arrow Articles by Boland, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goel, A.
Right arrow Articles by Boland, C. R.
Clinical Cancer Research Vol. 9, 383-390, January 2003
© 2003 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

A Novel Mechanism for Aspirin-mediated Growth Inhibition of Human Colon Cancer Cells1

Ajay Goel, Dong Kyung Chang, Luigi Ricciardiello, Christoph Gasche and C. Richard Boland2

Department of Medicine and Comprehensive Cancer Center, University of California San Diego, San Diego, California [A. G., D. K. C., L. R., C. G.], and San Diego Veteran Affairs Medical Center, La Jolla, California 92093-0688 [C. R. B.]

Purpose: The molecular mechanisms by which aspirin and other nonsteroidal anti-inflammatory drugs exert chemopreventative effects in colon cancer are unclear and complex. Current investigations focus on the chemopreventive properties of nonsteroidal anti-inflammatory drugs, independent of their ability to inhibit cyclooxygenase (COX) activity, and presumably, identification of non-COX pathways will suggest new targets for clinical use. It was demonstrated recently that aspirin results in reduced microsatellite instability in colorectal cancer cells. We hypothesized that aspirin treatment might alter expression of DNA mismatch repair (MMR) proteins, representing another potential non-COX mechanism for its action.

Experimental Design: In this study, we have examined the effects of aspirin on the cellular growth rates, MMR protein levels, cell cycle analysis and apoptosis in MMR-deficient (HCT116) and MMR-proficient (HCT116+chr3 and SW480) human colon cancer cell lines.

Results: We found that treatment with aspirin inhibited the growth of these three cancer cell lines. In HCT116+chr3 cells, treatment with 1 mM of aspirin increased expression of the hMLH1 and hPMS2 proteins by 2.5-fold and 2-fold, respectively, and increased expression of the hMSH2 and hMSH6 proteins by 2–3-fold. For SW480 cells, treatment with 1 and 5 mM of aspirin increased expression of the hMLH1 and hPMS2 proteins by 2–4-fold and 3–5-fold, respectively, and increased expression of the hMSH2 and hMSH6 proteins by 3–7-fold. For all three of the cell lines, treatment with 1 and 2.5 mM of aspirin induced apoptosis at 48 and 72 h. Aspirin induced G0/G1 cell cycle arrest in HCT116 cells.

Conclusions: We conclude that aspirin acts through COX-independent mechanisms by resulting in an increase in MMR protein expression and subsequent apoptosis, which might serve as an additional means of growth inhibition in aspirin-treated human colon cancer cells.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M.G. Luciani, C. Campregher, and C. Gasche
Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM
Carcinogenesis, October 1, 2007; 28(10): 2207 - 2217.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C R Boland, M G Luciani, C Gasche, and A Goel
INFECTION, INFLAMMATION, AND GASTROINTESTINAL CANCER
Gut, September 1, 2005; 54(9): 1321 - 1331.
[Full Text] [PDF]


Home page
Mol. Interv.Home page
A. Goel, C. Gasche, and C. R. Boland
Chemoprevention Goes Gourmet: Different Flavors of NO-Aspirin
Mol. Interv., August 1, 2005; 5(4): 207 - 210.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Fux, M. Schwab, K.-P. Thon, C. H. Gleiter, and P. Fritz
Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival
Clin. Cancer Res., July 1, 2005; 11(13): 4754 - 4760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Gasche, A. Goel, L. Natarajan, and C. R. Boland
Mesalazine Improves Replication Fidelity in Cultured Colorectal Cells
Cancer Res., May 15, 2005; 65(10): 3993 - 3997.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. J. Jang, H. J. Kang, J. R. Kim, and C. H. Yang
Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis
Carcinogenesis, October 1, 2004; 25(10): 1853 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Gehrmann, M. Brunner, K. Pfister, A. Reichle, E. Kremmer, and G. Multhoff
Differential Up-Regulation of Cytosolic and Membrane-Bound Heat Shock Protein 70 in Tumor Cells by Anti-Inflammatory Drugs
Clin. Cancer Res., May 15, 2004; 10(10): 3354 - 3364.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
R. Balzan, K. Sapienza, D. R. Galea, N. Vassallo, H. Frey, and W. H. Bannister
Aspirin commits yeast cells to apoptosis depending on carbon source
Microbiology, January 1, 2004; 150(1): 109 - 115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.